| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) | 
|---|
| 09/29/2011 | WO2011119860A1 Analogues for the treatment or prevention of flavivirus infections | 
| 09/29/2011 | WO2011119858A1 Analogues for the treatment or prevention of flavivirus infections | 
| 09/29/2011 | WO2011086531A3 New anti-malarial agents | 
| 09/29/2011 | US20110237783 Hydrazonopyrazole derivatives and their use as therapeutics | 
| 09/29/2011 | US20110237630 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof | 
| 09/29/2011 | US20110237589 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors | 
| 09/29/2011 | US20110237584 Kynurenine production inhibitor | 
| 09/29/2011 | US20110237576 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having bace1-inhibiting activity | 
| 09/29/2011 | US20110237573 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators | 
| 09/29/2011 | US20110237571 Phthalazine derivatives | 
| 09/29/2011 | US20110237568 Crystalline forms | 
| 09/29/2011 | US20110237559 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11Beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 | 
| 09/29/2011 | US20110236310 Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method | 
| 09/29/2011 | CA2792276A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | 
| 09/28/2011 | EP2368890A1 Hepatitis C virus inhibitors | 
| 09/28/2011 | EP2368889A1 Inhibitors of tyrosine kinases | 
| 09/28/2011 | EP2368886A1 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease | 
| 09/28/2011 | EP2368882A1 Anti-infective pyrimidines and uses thereof | 
| 09/28/2011 | EP2368880A1 6-(Heterocycle-Substituted Benzyl)-4-Oxoquinoline Compound and Use of the Same as HIV Integrase Inhibitor | 
| 09/28/2011 | EP2367820A2 Novel antimicrobials | 
| 09/28/2011 | EP2367817A1 Inhibitors of diacylglycerol acyltransferase | 
| 09/28/2011 | EP2367799A1 New compounds | 
| 09/28/2011 | EP2367598A2 Inhibitors of diacylglycerol acyltransferase | 
| 09/28/2011 | EP2148876B1 Pyrazolone derivatives as pde4 inhibitors | 
| 09/28/2011 | EP1966161B1 Carboxamides for controlling undesired micro-organisms in plant protection | 
| 09/28/2011 | EP1881827B1 Fused thiazole derivatives as kinase inhibitors | 
| 09/28/2011 | EP1697344B1 Hiv protease inhibiting compounds | 
| 09/28/2011 | CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same | 
| 09/28/2011 | CN102203075A Bicyclic kinase inhibitors | 
| 09/28/2011 | CN102203067A Hedgehog pathway modulators | 
| 09/28/2011 | CN102203065A Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists | 
| 09/28/2011 | CN102203059A Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof | 
| 09/28/2011 | CN102199150A Optical active oxazolidinone derivatives as well as preparation methods and application to preparing medicaments | 
| 09/28/2011 | CN102199144A Benzimidazole derivatives | 
| 09/28/2011 | CN101891738B Dasatinib polymorph and preparation method and medical composition thereof | 
| 09/28/2011 | CN101638410B Meloxicam compound and purifying method thereof | 
| 09/28/2011 | CN101633637B 8-oxo-8H-acenaphtho[1,2-b]pyrrole derivative | 
| 09/27/2011 | US8026371 Hydroxamates as therapeutic agents | 
| 09/27/2011 | US8026370 Peroxisome proliferator antagonist; hyperlipemia agents; arteriosclerosis; antiischemic agents | 
| 09/27/2011 | US8026367 (R)-arylalkylamino derivatives and pharmaceutical compositions containing them | 
| 09/27/2011 | US8026359 Fungicidal heterocyclic amines | 
| 09/27/2011 | US8026273 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient | 
| 09/27/2011 | US8026248 4-[[4-[(2,6-dichloro-phenyl)methyl]-6-[[2-(1-pyrrolidinyl)ethyl]amino]-2-pyrimidinyl]amino]benzonitrile; 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzamide, N1-oxide combined with another retrovirus inhibitor; viricides; treatment of AIDS | 
| 09/27/2011 | US8026241 Vanilloid receptor ligands and their use in treatments | 
| 09/27/2011 | CA2511307C Viral polymerase inhibitors | 
| 09/27/2011 | CA2457410C Compounds effecting glucokinase | 
| 09/27/2011 | CA2440630C Metalloproteinase inhibitors | 
| 09/27/2011 | CA2418109C Polymorphs of an epothilone analog | 
| 09/27/2011 | CA2258728C Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase | 
| 09/22/2011 | WO2011116336A1 Nitroxyl (hno) releasing compounds and uses thereof in treating diseases | 
| 09/22/2011 | WO2011116161A2 Arylsulfonamide ccr3 antagonists | 
| 09/22/2011 | WO2011115998A2 Modulators of hec1 activity and methods therefor | 
| 09/22/2011 | WO2011115173A1 Monomaleate of benzothiazine compound | 
| 09/22/2011 | WO2011115150A1 Method for producing benzothiazine compound | 
| 09/22/2011 | WO2011115069A1 Exhaustive searching for crystals | 
| 09/22/2011 | WO2011113756A1 Insecticidal compounds | 
| 09/22/2011 | WO2011113512A1 Morpholinylquinazolines | 
| 09/22/2011 | WO2011018474A8 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein | 
| 09/22/2011 | WO2010115000A3 Method of preparing an inhibitor of cytochrome p450 monooxygenase, and intermediates involved | 
| 09/22/2011 | US20110230657 Process for preparing quetiapine fumarate-toluene-water | 
| 09/22/2011 | US20110230550 Compounds, compositions and methods | 
| 09/22/2011 | US20110230521 Pyrazole Compounds As CCR1 Antagonists | 
| 09/22/2011 | US20110230505 Quinazoline inhibitors of bace 1 and methods of using | 
| 09/22/2011 | US20110230486 Modulators Of HEC1 Activity And Methods Therefor | 
| 09/22/2011 | US20110230477 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders | 
| 09/22/2011 | US20110230476 Pi3 kinase inhibitors and uses thereof | 
| 09/22/2011 | US20110230467 4,6-diaminonicotinamide compound | 
| 09/22/2011 | US20110230465 Viral polymerase inhibitors | 
| 09/22/2011 | US20110230463 2h-chromene compound and derivative thereof | 
| 09/22/2011 | US20110230457 Substituted Isoquinolinones and Quinazolinones | 
| 09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors | 
| 09/22/2011 | CA2793391A1 Arylsulfonamide ccr3 antagonists | 
| 09/22/2011 | CA2793311A1 Modulators of hec1 activity and methods therefor | 
| 09/22/2011 | CA2793299A1 Morpholinylquinazolines | 
| 09/22/2011 | CA2792168A1 Insecticidal compounds | 
| 09/21/2011 | EP2366703A1 Polymorph form of 2-amino (nitroaryl) thiazole derivative | 
| 09/21/2011 | EP2366698A1 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor | 
| 09/21/2011 | EP2366697A1 Guanidine compounds and use of same as binding partners for 5-HT5 receptors | 
| 09/21/2011 | EP2366392A1 Guanidine compounds and use of same as binding partners for 5-HT5 receptors | 
| 09/21/2011 | EP2365970A1 Pyridazinones and their use as btk inhibitors | 
| 09/21/2011 | EP2212282B1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof | 
| 09/21/2011 | EP1675835B1 Methods of preparation of dehydro-diketopiperazines in liquid phase or on solid supported phase | 
| 09/21/2011 | EP1505963B9 Hepatitis c virus inhibitors | 
| 09/21/2011 | CN1926134B 2-pyridinylethylcarboxamide derivatives and their use as fungicides | 
| 09/21/2011 | CN1864434B Wireless microphone communication system | 
| 09/21/2011 | CN102197031A Substituted 5-aminopyrazoles and use thereof | 
| 09/21/2011 | CN102190656A Oxazolidinone bacteriophage containing azaheterocycle | 
| 09/21/2011 | CN102190625A Stilbene tumor targeted medicine Combretastatin A4 analogs | 
| 09/21/2011 | CN101343250B Thrombopoietin mimetics | 
| 09/21/2011 | CN101282979B Composition containing chloromethyl phosphate derivative with improved stability and process for producing the same | 
| 09/20/2011 | US8022223 2-aminopyridine analogs as glucokinase activators | 
| 09/20/2011 | US8022222 Glucokinase activators | 
| 09/20/2011 | US8022210 3-Aminopyrazine-2-carbonylguanidine derivatives; (4-{4-[N'-(3,5-Diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}phenoxy)acetic acid 2-piperidin-1-yl-ethyl ester; hydration of mucous membranes; respiratory system and gastrointestinal disorders; skin, eye and vaginal dryness; hypotensive agents; asthma | 
| 09/20/2011 | US8022096 Pyrrolidine derivatives | 
| 09/20/2011 | US8022089 Isoxazoline-substituted benzamide compound and pesticide | 
| 09/20/2011 | US8022079 Methods of modulating PPAR gamma-type receptors | 
| 09/20/2011 | US8022073 Substituted pyridazine compounds and fungicidal uses thereof | 
| 09/20/2011 | US8022071 Nitrogenous heterocyclic compounds | 
| 09/20/2011 | US8022062 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists | 
| 09/20/2011 | US8022061 5-(Methoxymethyl)-1-(5-methyl-4-(thiophen-2-yl)pyrimidin-2-yl)-N-(pyridin-4-ylmethyl)-1H-pyrazole-4-carboxamide; for the treatment or prevention of type 2 diabetes and type 2 diabetes-related conditions |